Escolar Documentos
Profissional Documentos
Cultura Documentos
Patient
Advocates Pharma
Regulators
Our survey confirmed the Despite the buzz, it was clear that there is
considerable buzz about no consistently agreed upon definition for
the subject in the industry Patient Centricity
68% 63%
41% $
32% 27% 25%
10%
Nearly 70% reported that their organization Respondents were asked to select
has not been adequately successful with among multiple options.
patient-centric initiatives, and only 4%
reported a high degree of success.
Companies face four major barriers to success with their Patient Centricity initiatives
To learn more about how to overcome these barriers and how to make your
organization more patient centric, please contact:
SOURCE: IMSCG global industry-wide survey with 70 respondents drawn from large, medium, and small pharmaceutical and biotech manufacturers in the US and EU. Respondents represented senior marketing, research, and access related roles